i2E Managementi2E Managementi2E Managementi2E Management
  • About
  • Portfolio
  • Team
  • Funds
  • Investor Login

OMRF Glioblastoma Project

    Home library OMRF Glioblastoma Project
    NextPrevious

    OMRF Glioblastoma Project

    October 29, 2015
    0

    Glioblastoma Multiforme (GBM) is the most prevalent and aggressive type of malignant brain tumor in humans. At this time, there are no effective treatments available for this type of tumor. Standard treatments are painful, toxic, and highly invasive. Within the United States there are over 15,000 patients per year that die from glioblastoma multiforme, the most malignant form of gliomas. The National Cancer Institute reported globally over 176,000 individuals developed brain tumors in 2000 with an estimated mortality of 128,000. Despite multimodality treatment, survival is approximately 14 months. OMRF researchers have identified a compound, OKN-007, that has the unique ability to cross the blood-brain barrier and has been successfully shown to decrease both tumor size and tumor vasculature in animal models of glioblastoma. Based on OKN-007’s significant effect in reducing or eliminating glioblastoma in animal models and clinical trial safety data, OMRF intends to clinically evaluate the drug for its therapeutic effect against glioblastoma in humans.

    Avatar

    admin

    More posts by admin

    Related Projects:

    Alkami Technology

    View more

    Alkami Technology

    Alkami Technology

    Alkami Technology
    2015-12-29

    Benefit Informatics, Inc.

    View more

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.

    Benefit Informatics, Inc.
    2015-12-25

    BioLytx

    View more

    BioLytx

    BioLytx

    BioLytx
    2015-12-24

    Crescendo Bioscience

    View more

    Crescendo Bioscience

    Crescendo Bioscience

    Crescendo Bioscience
    2015-12-17

    Docvia

    View more

    Docvia

    Docvia
    2015-12-12

    Exaptive

    View more

    Exaptive

    Exaptive

    Exaptive
    2015-12-04

    Expert TA

    View more

    Expert TA

    Expert TA

    Expert TA
    2015-12-02

    Hyalose LLC

    View more

    Hyalose LLC

    Hyalose LLC

    Hyalose LLC
    2015-11-21

    • Disclaimer & Disclosure

    Oklahoma City Location

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305

    Click HERE for directions.

    Tulsa Location

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592

    Click HERE for directions.

    • Disclaimer & Disclosure
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • About
    • Portfolio
    • Team
    • Funds
    i2E Management